Patient Characteristics and Public Health Office Factors Associated With Long Reporting Delay of COVID-19 Cases in Sapporo City, Japan

Background: For therapeutic efficacy, molnupiravir and nirmatrelvir-ritonavir must be started to treat patients within 5 days of disease onset to treat patients with novel coronavirus disease 2019 (COVID-19). However, some patients spend more than 5 days from disease onset before reporting to the Pu...

Full description

Saved in:
Bibliographic Details
Published inJournal of Epidemiology Vol. 34; no. 3; pp. 129 - 136
Main Authors Watanuki, Daichi, Tamakoshi, Akiko, Kimura, Takashi, Asakura, Toshiaki, Saijo, Masayuki
Format Journal Article
LanguageEnglish
Published Japan Japan Epidemiological Association 05.03.2024
Subjects
Online AccessGet full text

Cover

Loading…